2型糖尿病并发脑梗死患者颈动脉粥样硬化与vWF、AT的关系
[Abstract]:Type 2 diabetes mellitus is a common disease. Cerebral infarction is one of the complications of large vessels and one of the main causes of death and disability in diabetic patients. Early screening and treatment of type 2 diabetes mellitus is necessary to prevent cerebral infarction. Atherosclerosis, vascular endothelial cell damage, vascular wall stenosis, and local thrombosis are the pathological basis of type 2 diabetes with macroangiopathy. The main cause of ischemic cerebrovascular events is atherosclerosis of the cervical vessels supplying blood to the brain, resulting in narrow vessel diameters or falling plaques. Studies have found that patients with type 2 diabetes complicated by cerebral infarction usually have abnormal changes in the vascular endothelial cell system, coagulation, anticoagulation and fibrinolysis system. Etiological factors (vWF) are recognized as plasma markers of vascular endothelial damage and dysfunction, and are closely related to the occurrence and prognosis of arterial thrombotic diseases. Several clinical studies have shown that the plasma vWF levels in patients with acute cerebral infarction are significantly elevated, suggesting that the elevated plasma vWF levels may be related to the pathological status of ischemic stroke. Relevant literatures reported that cerebral infarction, especially in acute phase, is in hypercoagulable state, and antithrombin (AT) is consumed in large quantities, resulting in hypercoagulability in blood vessels, and AT synthesis is reduced, suggesting that AT participates in the pathophysiological process of coagulation dysfunction in cerebral infarction. Objective: To investigate the relationship between carotid atherosclerosis and the expression of vWF and AT in plasma of type 2 diabetes mellitus patients with cerebral infarction, and to explore the relationship between the expression of vWF and AT and the process of type 2 diabetes mellitus complicated with cerebral infarction. Methods: From December 2015 to May 2016, 125 patients in Chengde Central Hospital were divided into three groups: (1) type 2 diabetes complicated with cerebral infarction group (DMCI group), n = 44; (2) type 2 diabetes mellitus group (DM group), n = 51. (3) pairs The control group (CN group), n = 30: healthy people who were checked up in the physical examination center of our hospital at the same time. According to the existence of carotid atherosclerotic plaques, each group was further divided into arterial plaque group (EAP group), non-arterial plaque group (NAP group); and then according to the different nature of the plaque, EAP group was divided into stable plaque group (SP group) and unstable plaque group (USP group). The subjects did not take anticoagulant, anticoagulant and thrombolytic drugs in the past month. The three groups were balanced in age and sex. All the subjects were asked about their medical history, height, weight, blood pressure, duration of diabetes, smoking history, and body mass index (BMI). Fasting venous blood was taken and measured by immunoturbidimetric method. The levels of plasma vWF, AT, triglyceride (TG), total cholesterol (TC), high density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C), glycosylated hemoglobin (Hb A1c) and color Doppler ultrasonography (CDU) were used to detect the three groups. Carotid plaque was analyzed by SPSS19.0 software. The normal distribution measurement data were expressed by mean (?) standard deviation. The comparison between the two groups was performed by t test. The comparison among the three groups was performed by analysis of variance (two comparisons were performed by LSD method). The counting data were analyzed by_~2 test. The difference was statistically significant (P 0.05). There was no significant difference in age and BMI among the three groups (P = 0.522, P = 0.1 (P 0.05). There was no significant difference in sex and smoking history among the three groups, _~2 = 3.56, P = 0.169 (P 0.05), _~2 = 2.688, P = 0.1261 (P 0.05); (2) The duration of DM in DMCI group was longer than that in DM group (P = 0.043) (P 0.05). There were significant differences in VWF, AT, Hb A1c, TC, HDL-C among the three groups (P 0.05); there was no significant difference in TG, LDL-C among the three groups (P 0.05); the comparison among the three groups: vWF, Hb A1c, TC in DMCI group were higher than those in DM group and CN group (P 0.05 or P 0.01), and the AT, HDL-C in DM group were lower than those in DM group and CN group (P 0.05 or P 0.01); the AT, HDL-C in DMCI group were lower than those in DM group and CN group (P 0.05 or P 0.01). The detection rate of carotid plaque in DMCI group and DM group was higher than that in CN group (_~2=27.81, P 0.01, _~2=4.67, P 0.05). The detection rate of carotid plaque in DMCI group was higher than that in DM group (_~2=13.44, P 0.01). (2) The detection rate of carotid plaque in three groups was statistically significant (P 0.01); the detection rate of carotid unstable plaque in DMCI group was higher than that in DM group, CN group (_~2=5.77, P 0.05, _~2=8.51, P 0.01). The detection rate of carotid artery unstable plaque in DM group was higher than that in CN group, but there was no significant difference (_~2=1.59, P 0.05). 4 The correlation between vWF level and carotid artery plaque properties in DMCI group was significant (1) The vWF level in DMCI group was significantly higher than that in DM group (P 0.05). The level of vWF in patients with stable plaque was significantly higher than that in patients without stable plaque (P = 0.023, P 0.05, P = 0.016, P 0.01); the level of vWF in patients with stable plaque was higher than that in patients without plaque, but the difference was not statistically significant (P = 0.129, P 0.05). (2) The relationship between AT level and the nature of carotid plaque in DMCI subgroups (?) The AT level of patients with unstable plaque was lower than that of patients without stable plaque (P = 0.038, P 0.05, P = 0.02, P 0.05). There was no significant difference between AT level of patients with stable plaque and that of patients without plaque (P = 0.103, P 0.05). The incidence of carotid atherosclerotic plaque in patients with diabetes mellitus complicated with cerebral infarction was significantly increased. The plasma vWF level in patients with type 2 diabetes complicated with cerebral infarction was associated with carotid atherosclerosis. The more unstable the plaque, the higher the vWF level was. The vWF could reflect the nature of carotid atherosclerotic plaque to some extent and could be used as an adjuvant. 3. The plasma AT level in type 2 diabetes mellitus patients with cerebral infarction is associated with carotid atherosclerosis, and the more unstable the plaque, the more obvious the decrease of AT level. AT can reflect the nature of carotid atherosclerotic plaque to a certain extent. 4. Type 2 diabetes mellitus patients with acute cerebral infarction The more serious vascular endothelial dysfunction, the more unstable carotid atherosclerotic plaque, the lower the level of vWF, the higher the level of AT, for the prevention and treatment of type 2 diabetes carotid atherosclerosis and cerebral infarction is of great significance.
【学位授予单位】:承德医学院
【学位级别】:硕士
【学位授予年份】:2017
【分类号】:R587.2;R743.33
【参考文献】
相关期刊论文 前10条
1 ;糖代谢异常与动脉粥样硬化性心血管疾病临床诊断和治疗指南[J];中华心血管病杂志;2015年06期
2 张津华;马丽丽;李江坤;苏建;付志新;;糖尿病合并脑梗死患者外周血T淋巴细胞亚群与基质金属蛋白酶9的相关性[J];中华老年心脑血管病杂志;2015年01期
3 Konstantinos Tziomalos;Marianna Spanou;Stella D Bouziana;Maria Papadopoulou;Vasilios Giampatzis;Stavroula Kostaki;Vasiliki Dourliou;Maria Tsopozidi;Christos Savopoulos;Apostolos I Hatzitolios;;Type 2 diabetes is associated with a worse functional outcome of ischemic stroke[J];World Journal of Diabetes;2014年06期
4 林旭红;魏丹丹;王慧超;徐静;王见涛;白春洋;王亚强;赵耀亭;李倩一;任学群;;动脉粥样硬化性脑梗死患者血浆抗凝血酶Ⅲ的变化及其机制[J];中国病理生理杂志;2014年09期
5 鞠晓华;谢宝明;张金彪;;2型糖尿病并发脑梗死患者联合检测血浆vWF水平及血小板参数的临床价值[J];实用临床医药杂志;2014年16期
6 马骏;陈锷峰;屠传建;钱辉;骆明;顾志伟;张建民;;急性高血压脑出血患者脑糖氧代谢变化及意义[J];中华急诊医学杂志;2014年03期
7 李千会;王彦富;李清贤;;2型糖尿病并冠心病患者vWF水平变化及其与冠脉病变程度、临床相关因素的关系[J];山东医药;2014年03期
8 李娜;任长虹;孙菲;李宁;吉训明;;脑梗死急性期患者血浆纤维蛋白原和D-二聚体及抗凝血酶Ⅲ水平的变化[J];中国脑血管病杂志;2013年05期
9 王富军;刘月芹;齐会卿;张玉娜;白磊;檀淼;高倩;;2型糖尿病下肢动脉病变介入治疗对缺血动脉内血管性血友病因子、纤维蛋白原的影响及其意义[J];临床荟萃;2013年02期
10 张鹏;汤荣华;;血管性血友病因子与抗凝血酶在糖尿病视网膜病变中的临床意义[J];血栓与止血学;2012年04期
,本文编号:2184420
本文链接:https://www.wllwen.com/yixuelunwen/shenjingyixue/2184420.html